Hepato-Pancreato-Biliary Cancers: Dr Gbenga Saka to Lead Online Oncology Session

Dr Gbenga Saka, Consultant Medical Oncologist at Milton Keynes University Hospital (MKUH), will lead an online educational session on hepato-pancreato-biliary (HPB) cancers on 13 October 2026. The session will explore advances in cancer diagnosis, treatment and patient care, with Continuing Medical Education (CME) credits available.

Hepato-pancreato-biliary cancers affect the liver, pancreas, bile ducts and gallbladder. These cancers can be challenging to diagnose at an early stage, making advances in medical imaging, treatment options and multidisciplinary care important areas of ongoing clinical discussion.

The online session is aimed at healthcare professionals, oncology practitioners and others interested in improving cancer outcomes.

Understanding Hepato-Pancreato-Biliary Cancers

Hepato-pancreato-biliary cancers, commonly known as HPB cancers, involve organs and structures associated with the liver, pancreas and biliary system.

Some of these cancers may not produce obvious symptoms in their early stages. Consequently, patients can sometimes receive a diagnosis after the disease has progressed, making early recognition, appropriate investigations and specialist assessment particularly important.

Improving awareness of these cancers and understanding current diagnostic approaches can help healthcare professionals make informed decisions about patient assessment and treatment planning.

Advances in HPB Cancer Diagnosis and Treatment

The session will focus on important developments in the diagnosis and management of hepato-pancreato-biliary cancers.

Topics will include advances in medical imaging, systemic cancer therapies, surgical treatment and multidisciplinary care.

Medical imaging helps clinicians identify tumours, assess disease progression and determine appropriate treatment options. Depending on the cancer type and stage, treatment may involve surgery, chemotherapy or other systemic therapies.

Multidisciplinary teams also play an important role by bringing together specialists from different areas of medicine to coordinate treatment plans around individual patient needs.

By exploring these developments, the session aims to encourage knowledge-sharing and discussion about approaches to managing complex cancers.

Dr Gbenga Saka to Lead Oncology Education Session

Dr Gbenga Saka is a Consultant Medical Oncologist at Milton Keynes University Hospital in the United Kingdom.

He will lead the discussion on HPB cancers, covering key updates in diagnosis, treatment and patient care.

The session provides an opportunity for healthcare professionals and oncology practitioners to engage with an important area of cancer medicine and strengthen their understanding of current approaches to patient management.

Continuing Medical Education (CME) credits will be available, according to the event announcement. Participants should confirm any applicable attendance and accreditation requirements with the organisers.

HPB Cancer Webinar: Date, Time and Zoom Details

The online oncology session is scheduled for Tuesday, 13 October 2026.

Event details:

• Topic: Hepato-Pancreato-Biliary Cancers
• Speaker: Dr Gbenga Saka
• Professional title: Consultant Medical Oncologist
• Institution: Milton Keynes University Hospital (MKUH)
• Date: 13 October 2026
• Time: 4:00 pm West Africa Time (WAT) / 10:00 am Central Standard Time (CST, UTC−6)
• CME credits: Available
• Platform: Zoom

Zoom joining information

• Meeting ID: 948 5304 9991
• Passcode: 635975

Participants should use the meeting details provided in the event announcement and check for any further instructions from the organisers.

Why Education on HPB Cancers Matters

Ongoing medical education helps healthcare professionals keep up with developments in cancer diagnosis, treatment and patient care. This is particularly relevant for complex cancers that may require input from several medical specialists.

The session with Dr Gbenga Saka will provide a forum to discuss developments in HPB oncology and the role of coordinated care in supporting patients throughout diagnosis and treatment.

Healthcare professionals, oncology practitioners and others interested in cancer management are encouraged to take note of the event details and join the online discussion.